Lineage Cell Therapeutics, Inc. (LCTX) Dividend Yield, History & Forecast

Lineage Cell Therapeutics, Inc. (LCTX) is a Biotechnology company in the Healthcare sector listed on the New York Stock Exchange Arca. The most recent ex-dividend date was December 15, 2003. market capitalization is approximately $391M.

Loading quote...

Frequently Asked Questions about Lineage Cell Therapeutics, Inc. (LCTX)

When does Lineage Cell Therapeutics, Inc. pay its next dividend?
The most recent ex-dividend date was December 15, 2003.
Is Lineage Cell Therapeutics, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Lineage Cell Therapeutics, Inc. in?
Lineage Cell Therapeutics, Inc. (LCTX) operates in the Healthcare sector, specifically the Biotechnology industry.